ostalo

Vox Markets Interview with Avacta CEO Alastair Smith

0

0

0 Pogledi· 09/19/23

The Vox Markets Podcast
0 Pretplatnici

U

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

Prikaži više

0 Komentari

Sljedeći

Auto Play

Dom

Istražite više

Pomozite